Cellosaurus logo
expasy logo

Cellosaurus UT-SCC-42B (CVCL_7848)

[Text version]
Cell line name UT-SCC-42B
Synonyms University of Turku-Squamous Cell Carcinoma-42B
Accession CVCL_7848
Resource Identification Initiative To cite this cell line use: UT-SCC-42B (RRID:CVCL_7848)
Comments Omics: Deep exome analysis.
Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
Disease Laryngeal squamous cell carcinoma (NCIt: C4044)
Squamous cell carcinoma of the larynx (ORDO: Orphanet_494550)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_7847 ! UT-SCC-42A
Sex of cell Male
Age at sampling 43Y
Category Cancer cell line
STR profile Source(s): PubMed=30135316

Markers:
AmelogeninX,Y
CSF1PO11,13
D2S133817,26
D3S135814
D5S81811
D7S8207,10
D8S117911,13
D13S3178,11
D16S53911,13
D18S5115
D19S43314,15.2
D21S1128,30
FGA22.2,23
TH019,9.3
TPOX8
vWA17,18

Run an STR similarity search on this cell line
Publications

PubMed=15287027; DOI=10.1002/gcc.20066
Takebayashi S., Hickson A., Ogawa T., Jung K.-Y., Mineta H., Ueda Y., Grenman R., Fisher S.G., Carey T.E.
Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer.
Genes Chromosomes Cancer 41:145-154(2004)

PubMed=17312569; DOI=10.1002/hed.20478
Lin C.J., Grandis J.R., Carey T.E., Gollin S.M., Whiteside T.L., Koch W.M., Ferris R.L., Lai S.Y.
Head and neck squamous cell carcinoma cell lines: established models and rationale for selection.
Head Neck 29:163-188(2007)

PubMed=30135316; DOI=10.1172/jci.insight.122204
Jamieson S.M.F., Tsai P., Kondratyev M.K., Budhani P., Liu A., Senzer N.N., Chiorean E.G., Jalal S.I., Nemunaitis J.J., Kee D., Shome A., Wong W.W., Li D., Poonawala-Lohani N., Kakadia P.M., Knowlton N.S., Lynch C.R.H., Hong C.R., Lee T.W., Grenman R., Caporiccio L., McKee T.D., Zaidi M., Butt S., Macann A.M.J., McIvor N.P., Chaplin J.M., Hicks K.O., Bohlander S.K., Wouters B.G., Hart C.P., Print C.G., Wilson W.R., Curran M.A., Hunter F.W.
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.
JCI Insight 3:e122204.1-e122204.19(2018)

DOI=10.1158/1538-7445.AM2020-507
Kondratyev M.K., Pesic A., Dvorkin-Sheva A., Ketela T., Moffat J., Koritzinsky M., Wouters B.G.
Repurposing of FDA approved drugs for treatment of metastatic HNSCC.
Cancer Res. 80 Suppl. 16:507-507(2020)

Cross-references
Encyclopedic resources Wikidata; Q54992131
Entry history
Entry creation04-Apr-2012
Last entry update29-Jun-2023
Version number13